Imaging chain pulls out of bankruptcy

Article

Medical Resources has closed the book on Chapter 11—and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the

Medical Resources has closed the book on Chapter 11-and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the remaining equity distributed to other creditors and plaintiffs in lawsuits. Pre–Chapter 11 shareholders will receive no distributions, and their shares of common stock will be canceled. With fewer than 300 record holders of its common stock, the company is no longer subject to the reporting requirements of the Securities Exchange Act of 1934. Medical Resources, which owns 70 imaging centers, marked completion of the restructuring by acquiring new MRI and CT scanners for its Springfield (PA) Diagnostic Imaging Center and Sarasota (FL) Outpatient affiliates.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.